Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient

Daniel G. Bausch; Heinz Feldmann; Thomas W. Geisbert; Mike Bray; A. G. Sprecher; Paul Boumandouki; Pierre E. Rollin; Cathy Roth

doi:10.1086/520542

Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient

Daniel G. Bausch, Heinz Feldmann, Thomas W. Geisbert, Mike Bray, A. G. Sprecher, Paul Boumandouki, Pierre E. Rollin, Cathy Roth

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies or vaccines and few clinical studies on the efficacy of supportive care. On 20 September 2006, experts from 14 countries representing 68 institutions integrally involved in the response to outbreaks of filovirus hemorrhagic fever gathered at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg to discuss possible remedies for this grim situation, in a unique workshop entitled "Marburg and Ebola Hemorrhagic Fever: Feasibility of Prophylaxis and Therapy." A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here.

Original language	English (US)
Pages (from-to)	S136-S141
Journal	Journal of Infectious Diseases
Volume	196
Issue number	SUPPL. 2
DOIs	https://doi.org/10.1086/520542
State	Published - Nov 15 2007
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Infectious Diseases

Access to Document

10.1086/520542

Cite this

@article{0e0187ff3d3a4e278bad0c2a8466026b,

title = "Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient",

abstract = "In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies or vaccines and few clinical studies on the efficacy of supportive care. On 20 September 2006, experts from 14 countries representing 68 institutions integrally involved in the response to outbreaks of filovirus hemorrhagic fever gathered at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg to discuss possible remedies for this grim situation, in a unique workshop entitled {"}Marburg and Ebola Hemorrhagic Fever: Feasibility of Prophylaxis and Therapy.{"} A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here.",

author = "Bausch, {Daniel G.} and Heinz Feldmann and Geisbert, {Thomas W.} and Mike Bray and Sprecher, {A. G.} and Paul Boumandouki and Rollin, {Pierre E.} and Cathy Roth",

note = "Funding Information: Supplement sponsorship. This article was published as part of a supplement entitled “Filoviruses: Recent Advances and Future Challenges,” sponsored by the Public Health Agency of Canada, the National Institutes of Health, the Canadian Institutes of Health Research, Cangene, CUH2A, Smith Carter, Hemisphere Engineering, Crucell, and the International Centre for Infectious Diseases.",

year = "2007",

month = nov,

day = "15",

doi = "10.1086/520542",

language = "English (US)",

volume = "196",

pages = "S136--S141",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "SUPPL. 2",

}

TY - JOUR

T1 - Outbreaks of filovirus hemorrhagic fever

T2 - Time to refocus on the patient

AU - Bausch, Daniel G.

AU - Feldmann, Heinz

AU - Geisbert, Thomas W.

AU - Bray, Mike

AU - Sprecher, A. G.

AU - Boumandouki, Paul

AU - Rollin, Pierre E.

AU - Roth, Cathy

N1 - Funding Information: Supplement sponsorship. This article was published as part of a supplement entitled “Filoviruses: Recent Advances and Future Challenges,” sponsored by the Public Health Agency of Canada, the National Institutes of Health, the Canadian Institutes of Health Research, Cangene, CUH2A, Smith Carter, Hemisphere Engineering, Crucell, and the International Centre for Infectious Diseases.

PY - 2007/11/15

Y1 - 2007/11/15

N2 - In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies or vaccines and few clinical studies on the efficacy of supportive care. On 20 September 2006, experts from 14 countries representing 68 institutions integrally involved in the response to outbreaks of filovirus hemorrhagic fever gathered at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg to discuss possible remedies for this grim situation, in a unique workshop entitled "Marburg and Ebola Hemorrhagic Fever: Feasibility of Prophylaxis and Therapy." A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here.

AB - In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies or vaccines and few clinical studies on the efficacy of supportive care. On 20 September 2006, experts from 14 countries representing 68 institutions integrally involved in the response to outbreaks of filovirus hemorrhagic fever gathered at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg to discuss possible remedies for this grim situation, in a unique workshop entitled "Marburg and Ebola Hemorrhagic Fever: Feasibility of Prophylaxis and Therapy." A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here.

UR - http://www.scopus.com/inward/record.url?scp=38449108229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449108229&partnerID=8YFLogxK

U2 - 10.1086/520542

DO - 10.1086/520542

M3 - Article

C2 - 17940941

AN - SCOPUS:38449108229

SN - 0022-1899

VL - 196

SP - S136-S141

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - SUPPL. 2

ER -

Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this